Somatuline Depot 90 mg/0.3 mL prefilled syringe Images
Generic Name: lanreotide
This medication has been identified as Somatuline Depot 90 mg/0.3 mL prefilled syringe. It is supplied by Ipsen Biopharmaceuticals, Inc.
Somatuline Depot is used in the treatment of Neuroendocrine Carcinoma; Carcinoid Syndrome; Acromegaly and belongs to the drug class somatostatin and somatostatin analogs. Risk cannot be ruled out during pregnancy. Somatuline Depot 90 mg/0.3 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Somatuline Depot
- Generic Name
- lanreotide
- Strength
- 90 mg/0.3 mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Somatostatin and somatostatin analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ipsen Biopharmaceuticals, Inc.
- National Drug Code (NDC)
- 15054-1090
More about Somatuline Depot (lanreotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
